Urinary [TIMP-2]•[IGFBP7] performed better than any other biomarker reported to date for predicting the development of moderate or severe AKI according to Kidney Disease Improving Global Outcomes (KDIGO) criteria in patients at high risk for AKI from multiple causes [23]. This evidence concerns the gene IGFBP7 and acute kidney injury.